<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by D. Taylor on Medium]]></title>
        <description><![CDATA[Stories by D. Taylor on Medium]]></description>
        <link>https://medium.com/@damaristaylor?source=rss-3e7c808119e9------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*IplDXyULVCtVJfPfwunKdQ.jpeg</url>
            <title>Stories by D. Taylor on Medium</title>
            <link>https://medium.com/@damaristaylor?source=rss-3e7c808119e9------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Tue, 17 Nov 2026 00:35:27 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@damaristaylor/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Good morning,]]></title>
            <link>https://medium.com/@damaristaylor/good-morning-f6e4c057f6d5?source=rss-3e7c808119e9------2</link>
            <guid isPermaLink="false">https://medium.com/p/f6e4c057f6d5</guid>
            <category><![CDATA[mental-health]]></category>
            <category><![CDATA[bipolar]]></category>
            <dc:creator><![CDATA[D. Taylor]]></dc:creator>
            <pubDate>Wed, 01 Jun 2016 19:52:53 GMT</pubDate>
            <atom:updated>2016-06-01T19:52:53.612Z</atom:updated>
            <content:encoded><![CDATA[<p>Good morning,</p><p>I read the story you posted about bipolar disorder. Such a tricky disorder. It is misunderstood, confused, glamorized, and feared. Although, I don’t know of a mental disorder that is not treated this way in American culture. I began reading about the disorder when I was 23. My first brush with an “acute” suicide attempt left my family in confusion; it gave my friends an excuse to distance themselves. I do not know why the disorder chose me. My family history is sprinkled with a relative here, a great aunt there. All of them afflicted with bipolar disorder. It seemed out of reach to me. These relatives who were so far removed that I could not see their faces, and I cannot remember their names. This fact finding mission I was on to uncover the effects of the disorder left me with more questions than it ever did answers. I can only speak to my own experience. Bipolar disorder is a difficult journey. From what I have seen in hospital, it manifests in different ways. For some, it is a euphoric high. For others, it is a decent into an angered madness. I have been told by doctors that those afflicted with the malady should not drink. The warming effects of alcohol quicken the temper and further decent.</p><p>For ten years, I had been symptom free. I took the prescribed medications, went to bi-weekly meetings with my therapist, and saw my doctor every three months. At the age of 30, I broke up with my boyfriend. The next three years became an unmedicated search for meaning. Not necessarily a search for god, just a search for the words to explain my affliction. I was productive, creative, abstinent from drugs and alcohol. I went to yoga every day. And then, I decided I wanted to search for my future husband. I took on online dating as a hobby. A date almost every night kept me occupied. I just needed something that wasn’t the boredom of going home to nothing, no one. The banal existence of everyday life was creeping in. I didn’t realize this was a mania setting in.</p><p>At 33, my “acute” symptoms presented. The spring is never an easy time of year for me. I had experienced loss, frustration, and love. Anger was a staple in my home. It bleed from every conversation. It presented at every opportunity. So much so that the police were called on me several times. What my doctors call rapid cycling is what the police call violence. Although I did not harm anyone, I am loud and I create a panic. I have pictures to prove the abuse, I have a recording of the 911 call, and the police report to corroborate. No matter how many times I explained, they went back to what they thought their story was. I never got an opportunity to explain my side of the story. Two years later, the court case was dismissed. I am unstable — at least that’s what he says.</p><p>The medication they prescribed after my last stint in the hospital has left me unable to concentrate. The stories in my mind have disappeared; what you would call an inner monologue. It’s 9:28AM and I’m sitting at my computer at work thinking about the affects of bipolar disorder. The impact it has had on my self-esteem, mental health, and friendships has been one of difficulty. I am not a perfect person, but I have found a job which is fulfilling. What keeps that in balance is that my co-workers do not know. After 10 years of working in pharmacy, I know better than to disclose too much. I have heard the comments. I have experienced the hate. I have lost a job over my disclosure. So now, I keep it to myself. For some reason, I feel that this is the only safe outlet for me to write.</p><p>My soon to be ex-husband has banned me from every social media outlet. He has coerced me into admitting that it’s my mental health, not his anger, that is the problem. The gas-lighting has become unreasonable. Do look it up. It’s quite a fancy tactic that abusers use. Even though I am seeking treatment, he has given up. At least I have my dog. He is the only one who comforts me in those lonely moments when I cannot get out of bed. What I do recommend is NAMI, DBSA support alliance, and a fuzzy friend. Even if my soon to be ex has told me that I should have been sterilized when I found out that I had this disorder, I am not a bad person. I am completing my masters degree, working a job, and taking care of my fur baby. Finances are difficult, but I keep reaching out to get the treatment I need. If you are like me, don’t give up. Message me and you can call any time. I am here.</p><p>Thanks for listening.</p><p>D.T.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=f6e4c057f6d5" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Selling Sickness]]></title>
            <link>https://medium.com/@damaristaylor/selling-sickness-fca6da1f4988?source=rss-3e7c808119e9------2</link>
            <guid isPermaLink="false">https://medium.com/p/fca6da1f4988</guid>
            <category><![CDATA[mental-health]]></category>
            <category><![CDATA[mental-illness]]></category>
            <dc:creator><![CDATA[D. Taylor]]></dc:creator>
            <pubDate>Wed, 01 Jun 2016 19:34:46 GMT</pubDate>
            <atom:updated>2016-06-01T19:34:46.590Z</atom:updated>
            <content:encoded><![CDATA[<p><em>Manic Depression is actually a malady of social conformity- Emily Martin</em></p><p>Through direct to consumer marketing, pharmaceutical companies have been able to reach a wider audience and inform the public about a psychiatric medical model of health. Because the “selling has become as sophisticated as the science,” technologically has subjectified the human experience and prescribed mood altering medications for a broad spectrum of disorders they believe inhibit social functioning (Selling Sickness). By doing so, the personal performance of illness has been redefined, internalized and materialistically focused. As societies understanding of mental illness changes, patients are expected to take on a variety of roles in relation to their illness, and how we model self in relation to mental illnesses can no longer be compared to a binary system. The transformation of the term manic-depression into bipolarity mollifies and perpetuates the ideals of social conformity through political, social and personal spheres by challenging the agency and understanding of the true condition.</p><p>Throughout this paper I discuss how the personal affliction of manic-depressive disorder transformed in relation to biovalue and how the bipolarity of social conformity is self evident in relation to the internalization of emotions. The second topic I will discuss is how society dictates what performance is expected from persons diagnosed with disorders and how these attitudes recourse in relation to the changing times. The third perspective is how political institutions take on a bipolarity of expectation. They expect the citizen to become and advocate, but resign to a regimen of medication. Contrasting societal expectations not only confuse this condition, but influence how each genre defines manic-depression. The danger here is that overproducing terms makes them palatable, thus common place. In truth, these conditions are serious afflictions that need to be granted the respect they deserve. I conclude that the term bipolar challenges the true malady of conformity and allows for the mass marketing of medications through the terms normalization.</p><p>Bipolarity is used to define extremes or polarizations, but the two sided argument is insufficient when referring to the severity of manic-depression disorder. Within the stratification of social order, bipolarity references contrasting ideas. As Dr. Kay Jamison explains, “separation of moods implied by the term bipolar perpetuates the notion that depression exists rather tidily segregated on its own pole, while mania clusters off neatly and discreetly on another” (Martin 28). This definition ignores periods of remission, co-morbidities associated with the condition and external influences on the disorder. The titrating and tapering anterior qualities denoted by this condition <em>imply</em> a stair step approach to diagnosis, yet rigid calculations are prescribed. The disorders mood criteria exist within states of hyper, hypo, mild, major, mixed or rapid cycling versions of manic and depressive symptoms. Due to the disorders complexity, the term bipolar fails to address these fluctuations.</p><p>The Diagnostic and Statistical Manual of Mental Disorders (DSM) has an overly analytical definition which becomes a modulated tool of diagnostic criteria. The diagnostic specificity is used in proportion to the administration of billing insurance companies, pharmaceutical labeling of prescription medication and a preponderance of newly creation conditions. It is here that “science is a production of convincing knowledge in modern society” (Marks 2). Mental illnesses such as social anxiety disorder and manic-depressive disorder become mainstreamed conditions. Every part of the personality can now be optimized and mass marketed, which puts humanity in danger when everyday living becomes a disorder.</p><p>The deinstitutionalization of mental hospitals and psychoanalytic treatment impacted how the DSM was defined. As Mays &amp; Horowitz explain, “psychiatrists increasingly turned to drugs as treatment, especially for four categories of mental illness…psychosis, depression, anxiety and manic-depressive disorder” (255). These four categories began to expand with each edition of the DSM. In order to be reimbursed by insurance carriers, psychiatrists began defining mental illness in terms of diagnosis codes which conformed to the norms of biomedicine. As Martin explains, the code denotes the illness within a category and the numbers after the decimal indicate the nature then severity of the most recent episode (135). The sole purpose of this delineation became a pragmatic approach to the incorporation of biovalue into the field of psychiatric care. Mays &amp; Horowitz critic the DSM, explaining that “the paradigm shift in the mental health diagnosis in the DSM-III was neither a product of growing scientific knowledge nor of increasing medicalization” (249).</p><p>During the 1960s, critics of psychiatry, like Thomas Szasz and Michael Foucault, challenged the creditability of these classification systems. These categories marginalized nonconformist behavior and “emerged in a complex field of power relations” (252). Behaviors that do not meet the criteria of societal standards could then be diagnosed, labeled and treated by the medical model of psychiatry. This enabled psychiatry to deconstruct social performances of mentality and emotion according to existing social criteria and enforce the popular opinion of normality. Manic-depressives display extremes of emotions, but how are these moods identified in a society that values docile responses? Martens explains that “people performing ‘bipolar’ or ‘borderline’ destabilize ideas of being and knowing but in different ways,” and this performance “challenges dominant social norms for economic participation, self-government, bodily care and relational/familial expectations… Some of these traverses are seen in a positive light, while others…are pathologized” (4). The condition becomes ostracized in relation to biocitizenship.</p><p>On the person level, redefining manic-depression has had minimal impact on the person diagnosed. The stigma that is attached to this condition remains the same, no matter what the term. This label affects the person by challenging their ideas of rationality, agency and personhood. Emily Martin calls the argument of rationality “double book keeping.” Even in irrationality, the manic depressive is aware of the rational, so which are they? The bipolar language of the DSM manifests in relation not to how the patients see’s themselves but to how the doctor defines their behavior. Because students of psychiatry have been exposed to the same model of manic-depressive behavior, the lived expressions of this disorder become opaque. Showing that actions do not define the individual, Martin explains that the “performance matters in a different way: performance provides a way, in actions as well as words, for people cast into this category of the irrational to comment <em>on </em>their putative ‘irrationality.’ In so demonstrate that they <em>are</em> rational” (59). So then how do you convince a doctor that they have misdiagnosed you?</p><p>How society interprets the condition causes the person diagnosed to either subscribe to the condition or the defy treatment. For a manic depressive, doctors state that treatment is difficult and after a diagnosis is fixed, denial is a common response to the label. People who knew very little about the condition before will swallow books full of information in hopes that they will uncover how they fit into this condition. Biocitizenship takes the form of a responsible consumer of information. This label comes with the amendment of medical care, treatment and prescriptions possibly for life and for many, is not taken lightly. Because the condition is tangled within emotional responses, the severity of the condition can be attributed to any person at a specific period in their life. The difference here is that emotion regulation for the manic depressive is not an act of choice. Yet in a society that values the internalization of emotions, can we gender diagnosis or marketing response? Martin explores the observer’s bias and how this could affect diagnostics. She questions whether the “disorders themselves already have cultural assumptions embedded in them…[and] if the interests of product-centered pharmaceutical corporations dovetail with seeing psychological states as physical states, extricable from social context” (275)?</p><p>The prevalence of co-morbidities in manic depression makes this disorder difficult to differentiate and easy to misdiagnosed. Common disorders associated with manic depression are: alcoholism, anxiety, ADHD, Borderline Personality disorder, eating disorders, OCD, and substance abuse problems. Due to the high instances of co-occurring disorders and an increasing cultural preference for internalized emotions, many mental illnesses are under diagnosed or misdiagnosed. When patients do see help, doctors commonly misinterpret symptoms of manic depression as something else; women are more commonly diagnosed with depression and men with schizophrenia (WHO). Women being syndicated as the more “emotional” sex are more often categorized as having anxiety disorders, depression, or somatic complaints, while men are stereotyped as having ADHD, antisocial behavior disorder and schizophrenia (WHO). Many of these disorders are open to interpretation and become socially inscribed disorders because “our very personhood is increasingly being defined by others and by ourselves in terms of our contemporary understandings of the possibilities and limits of our corporality” (Rose 76).</p><p>As science explores new ways to ameliorate disease and distress, pharmaceutical companies have capitalized on optimizing human functioning. After the FDA approved pharmaceutical marketing of drugs directly to consumers, television commercials and media advertisements transformed society’s ideas of what mental health and mental illness looked like, as well as what it should be. This process of advertising sells a dream of health and happiness while encouraging the person to self diagnose. They, in turn, ask their doctor to prescribe a medication that drug representatives have provided samples for. Because of this marketing, the American public has developed a hyper-sensitivity to mental illness and the prospect that they themselves may be suffering from this condition. Existing within a capitalistic society that subject’s its citizens to insurmountable levels of stress, and relies on quick fixes, has caused citizens to turn to pills in order to ease the suffering of everyday life.</p><p>Psycho-pharmaceuticals during the “1980s became based on the use of drugs to maintain persons with mental disorders outside the asylum, [and]drugs were largely marketed on the basis of their capacity to enable individuals to cope with life in the community” (Rose 210). For many manic depressives, life in the community begins after being discharged from the hospital. They leave with a preponderance of medications, ranging from benzodiazepines to mood stabilizers to antipsychotics. Each pill has a personality and for that patient, the molecularizing qualities pharmaceutical have on their body can create its own stigma. The word antipsychotic attached to the medication can arouse fear and trepidation. A few drugs in this class include Zyprexa, Seroquel, Risperdal and Ability which can all cause weight gain, depression, and suicidal thoughts. In a society that values being thin, weight gain can exacerbate depression or depression can be a side effect of the medication, not a persistence of the original malady. In this case, side effects become as important as the drugs performance. Being able to effectively regiment a patient’s treatment according to their own idiosyncrasies aids the doctors in prescribing medications that they will take because no one wants to adhere to a treatment that is as bad as the condition.</p><p>Abilify is a third generation antipsychotic, and one of the first drugs mass marketed through the use of commercials for the treatment of persistent depression and manic depressive disorder. Because SSRI’s alone can exacerbate symptoms of manic depression and bring a potential for adverse reactions, marketing for both is a way to tap into this uncharted market while staying away from the label this condition prescribes (CHAAD). In an era where television ads are substituting for an informed doctor, the dangers of coercive medication marketing are shown by the Abilify warnings not mentioned on the television, “remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects”(WebMD). Listed as an antipsychotic, Abilify is the first drug in this category to be approved for the treatment of depression. This class of drug has never been a typical treatment for depression and even now it is not a common one. While other antipsychotics are pending approval, consumers and doctors are being led to believe that these medications are safe and effective in the secondary treatment of depression. I argue that the use of the term bipolar in the commercials has allowed the drug companies to soften the condition, blind side consumers and mass market a severe condition that should not be treated as a common malady.</p><p>Because the social context of a disorder remains the most prevalent indicator of what behaviors deviate from the norm, mental distress and <em>not</em> illness becomes a target for the pharmaceutical industry. Reactions to stressors within everyday existence can be marketed as psychological disorders. At the opposite end of the spectrum, if a person has the capacity to rationalize and interiorize the mundane irritants of life then they are seen as healthy. It is when the performance of emotion escalates to a momentary extreme that these conditions are called into question. The pharmaceutical companies have a keen awareness of what social forces cause discomfort in our lives and due to societal influences, we are expected to mask these conditions to be seen as functioning members of society. As these norms shift, so must our psychiatric interpretations. This prevails through our “attempts to universalize performances of distress through increasingly detailed lists of normative criteria and increasingly fine delineations between categories to show that the strength of the classificatory process is its ability to widen or narrow depending on its object of view, the purpose of that view, and socio-cultural evaluations of the ‘object’ in question” (Martens 6). In this case, it is what the drug companies choose for us to see; the happy faces on an Abilify commercial.</p><p>Aggressive drug marketing has become a circular malady that creates a cause for the person to be medicated, and the medication in turn subjectifies the person. The person then becomes dependent on the medication to maintain somatic normality and social conformity. This process shapes a perception of what it is to be ill and what it looks like to be well. By molecularizing the human brain, a power structure has been established between the prescriber, the person and the medication. Relationships to these drugs are “embedded in a matrix of <em>socia</em>l values and expectations…[and] can be used to improve social relationships, by bringing one’s behavior (and emotions) into an idealized model of ‘normal’ behavior” (Helman 202). It is in the bipolar definition of emotion that a relationship to the science of social behavior is forged and confined. Foucault argues that science “became the means by which the state has increasingly gained more power over our bodies, by becoming the official arbiter of what may be considered ‘normal’ and ‘abnormal.’ The more narrowly science defines what is normal, the more the state controls us” (Marks 69). By investing in mental illness as a molecular abnormality, society has allowed governing entities to possess personal agency of these individuals at a distance. The body has become not only a sight of optimization but of biovalue.</p><p>Selling sickness has become a lucrative business. As a responsible biocitizen within a market-driven culture, Rose explains how “consumerist action becomes naturalized as a notion of freedom and the idea of citizen changes from historical member of community with the ability to exercise political power and the obtaining of civil rights to one of an independent individual exercising freedom through the economic market-place” (Martens 3). Pharmaceutical companies have become a mechanism of the structural normative in health that reinforces their own political agenda while causing the public to believe they are acting on their own accord. The biocitizen is then so consumed by their somatic experience and the ability to manipulate performance that it runs the risk of neglecting serious side effects and any consequences that may ensue from its cessation. An example of this is how consumers have been numbed by the laundry list of “may cause” clauses at the end of commercials. Instead they focus on smiling faces and the “new ideas about illnesses and conditions that are embraced by both patients and physicians,” yet ignore how “industry might sometimes influence the very way conditions are being defined“(Selling Sickness).</p><p>Where before, Rose states, “mental disorders were pathologies, a drain on the national economy. Today, they are vital opportunities for the creation of private profit and national economic growth” (Rose209). Because health is a symbol of wealth in society, investors in pharmaceutical industries spend billions of dollars each year to research and marketing these “miracle cures” that will restore a person to their perception of health. Many of the drugs on the market today have been prescribed without knowing the consequence of their nature. With each new side effect, a new drug is marketed that will alleviate the symptoms. Selling not only the newest drugs, but the newest disorders has given the manufacturer of Abilify the advantage. They are marketing the newest medication for an old disorder under a new name, bipolar.</p><p>The relationship between the pharmaceutical industries, the government and the FDA is a complex and advantageous one. During clinical trials, prescription drugs have to prove efficacy in comparison to placebos, not to other drugs in the same class. This controlled process does not have to prove whether the newest drugs on the market work better or the same as its predecessors. The pharmaceutical industries innovation for maintaining or reinventing patents parallels with biovalue. Originally used as a drug to treat schizophrenia, Abilify crossed categories as an off-label antidepressant. By choosing this route, manufacturers perform a preliminary clinical trial and then use the data to apply for a FDA approved antidepressant market. Although off-label uses are common, they are not proven effective, yet in the pharmaceutical market it does extend the patent. CHADD cites these examples for comparison:</p><p>· <strong>According to a recent study, 96% of all “off-label” psychiatric drug prescriptions lacked scientific support</strong></p><p>· <strong>The percentage of FDA workers who are paid directly through funding from the pharmaceutical industry: 55% at an average of $1.2 billion annually</strong></p><p>· <strong>Out of the last 20 FDA commissioners, upon leaving the FDA, the number who went to work directly for the pharmaceutical industry: 12</strong></p><p>· <strong>The major stockholders of the pharmaceutical industry: FDA workers, FTC workers, Congressmen, &amp; the CEO’s of the pharmaceutical companies.</strong></p><p>Government involvement in mental health issues has typically been restricted to issues surrounding publically allocated funds and capitalistic productivity. Representatives levy policies in relation to individuals requesting services from the state or in hopes of increasing profit margins. One popular form of screening for mental illness has been through welfare offices. Government agents hand out forms for individuals to fill out and while they are waiting in the office to receive their check, they are being screened for depression (Martin 190). Similar to how the welfare offices have been used to generate pre-patients for the drug companies to medicate; the New Freedom Commission on Mental Health has had a similar purpose. Under President George Bush’s administration, the program ran under the name Texas Medical Algorithm Project (TMAP). After proving to be a successful market in the state’s prison systems, it was scheduled to begin trial in the Texas schools. The Texas House of Representatives fought this governmental invasion by passing the Parental Consent Act of 2005. This act prohibits federal funding from being used to screen school aged children for mental illnesses. It also requires that any testing performed must be done under the consent of a parent. Unfortunately, this did not inhibit Texas school systems from being used as a clinical trial for Zyprexa.</p><p>Throughout all the various revisions of to direct to consumer marketing, the pharmaceutical industry “reveals a more complex process of the intertwined production of the disorder and its treatment” (Rose 211). As societies understanding of mental illness refines and becomes an instrument for biosocial value, the truth of its conviction is lost. When manic depression was translated into bipolar disorder, the word became palatable and readily commodified. The effect of this linguistic transformation tapered from political to social to personal. Unlike manic depressive moods that cycle and oscillate, American society is bipolar. There are binaries of wealth, control and value prescribed on every citizen. The challenge here is confronting those who are selling the sickness.</p><p>Bibliography:</p><p>“Drugs &amp; Medications- Abilify Oral Side Effects.” <em>WebMD</em>. WebMD, n.d. Web. 20 Apr 2010. &lt;http://www.webmd.com/drugs/drug-64439-Abilify+Oral.aspx?drugid=64439&amp;drugname=Abilify+Oral&amp;source=3&gt;.</p><p>“Facts and Statistics.” <em>Children and Adults Against Drugging America</em>. Chaada, 2004. Web. 20 Apr 2010. &lt;http://www.chaada.org/Page3.html&gt;.</p><p>Helman, Cecil G. <em>Culture, Health and Illness</em>. 3rd. Oxford: Butterworth-Heinemann Ltd, 1994. 194–223. Print.</p><p>Marks, Jonathan. <em>Why I Am Not a Scientist</em>. Berkley and Los Angeles: University of California Press, 2009. Print.</p><p>Martens, Christina. “Theorizing distress: Critical Reflections on Bi-polar and Borderline.” <em>Radical Psychology </em>7.2 (2008): n. page. Web. 29 Apr 2010. &lt;http://radicalpsychology.org/vol7-2/Martens.html&gt;.</p><p>Martin, Emily. <em>Bipolar Expeditions</em>. Princeton: Princeton University Press, 2007. Print.</p><p>Mayes, Rick, and Allan V Horwitz. “DSM-III anf the Revolution in the Classification of Mental Illness.”<em>Journal of the History of the Behavioral Sciences</em>. 41.3 (2005): 249–267. Print.</p><p>Rose, Nikolas. <em>The Politics of Life Itself</em>. Princeton: Princeton University Press, 2007. Print.</p><p>WHO. “Gender and women.” <em>Mental Health</em>. World Health Organization, 2010. Web. 11 May 2010. &lt;http://www.who.int/mental_health/prevention/genderwomen/en/&gt;.</p><p>“Selling Sickness.”<em>YouTube</em>. Web. 25 Apr 2010. &lt;http://www.youtube.com/watch?v=v5Q1MkDbVEU&gt;.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=fca6da1f4988" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>